AQUELA JALALYAR: Open Payments
NPI 1841920907 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,735 in 96 payments from 14 companies in 2025. Trend: 2023 $314 · 2024 $1,030 · 2025 $1,735
Food & beverage: $1,692Education: $43
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $470 |
| ABBVIE INC. | 22 | $385 |
| UCB, Inc. | 16 | $201 |
| Regeneron Healthcare Solutions, Inc. | 10 | $151 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| Lilly USA, LLC | 3 | $77 |
| Organon LLC | 6 | $70 |
| E.R. Squibb & Sons, L.L.C. | 4 | $59 |
| GENZYME CORPORATION | 2 | $56 |
| Galderma Laboratories, L.P. | 1 | $37 |
Products named: TREMFYA, RINVOQ, Bimzelx, DUPIXENT, COSENTYX, LIBTAYO, Sotyktu, TALTZ.
Industry payments across WA — which companies pay providers there.
